Antimicrobial Resistance and Associated Risk Factors for Clostridium difficile in Patients Attending Tertiary Care Settings

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Total samples n (%) positive by ELISA</td><td class="align_center">No. of positive samples n (%)</td><td class="align_center">Toxin status</td><td class="align_center">Toxin A ELISA</td><td class="align_center">Toxin A/B ELISA</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left" rowspan="3">115/450 (25.5)</td><td class="align_center">41 (35.6)</td><td class="align_center">A+/B+</td><td class="align_center">+</td><td class="align_center">+</td></tr><tr><td class="align_center">23 (20)</td><td class="align_center">A−/B+</td><td class="align_center">−</td><td class="align_center">+</td></tr><tr><td class="align_center">51 (44.4)</td><td class="align_center">A−/B−</td><td class="align_center">−</td><td class="align_center">−</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Frequency of toxigenic strains of C. difficile based on A and B toxins ELISA.</div>

Journal of Tropical Medicine

tab4

Table 4

Table 4: Antimicrobial Resistance and Associated Risk Factors for Clostridium difficile in Patients Attending Tertiary Care Settings